Parkinson's Disease Trial, Recruiting NCT05741151 Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT05741151
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Parkinson's disease according to the standards set by the Movement Disorder Society.

Who may not be able to join:

  • People who have clear signs of problems with a part of the brain called the cerebellum, such as a cerebellar-related walking difficulty, poor limb coordination, or certain abnormal eye movements (confirm with trial site)
  • People who have difficulty moving their eyes in a downward direction, or whose downward eye movements are noticeably slower than normal
  • People who have been diagnosed with a specific type of dementia affecting behaviour, or a condition causing progressive loss of language ability, within the first 5 years of their illness
  • People whose Parkinson's-like symptoms have only ever affected the lower half of their body for more than 3 years
  • People who are taking medication that blocks or reduces dopamine in a way that could itself be causing their Parkinson's-like symptoms
  • People whose symptoms have not responded at all to high doses of a medication called levodopa, despite having a moderate or more severe level of disease
  • People who have clear loss of certain types of touch or sensation, difficulty performing purposeful movements with their limbs, or progressive loss of language ability
  • People whose brain imaging shows normal results for the dopamine system in a specific area of the brain (confirm with trial site)
  • People whose symptoms are more likely explained by a different condition than Parkinson's disease, based on medical records or expert medical assessment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +39 06 3015 5031

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 January 2023
Est. completion
31 December 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Capacity of the Superior Cervical Ganglion in parkinsonian patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov